TRFE · Trustfeed Corp. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | $6.2K | $14.5K | $13.6K | - | $21.5K | - | - | - | $4.5K |
| Cost of Revenue | - | $1.8K | $1.6K | $10.9K | - | $985 | - | - | - | - |
| Gross Profit | - | $4.3K | $3.8K | $2.7K | - | $8.9K | - | - | - | $4.5K |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | $619.0K | $556.7K | $398.8K | - | $256.3K | $20.1K | $69.0K | - | $70.7K |
| Total Operating Expenses | - | $633.1K | $567.2K | $418.6K | - | $268.0K | $20.1K | $69.0K | - | $70.7K |
| D&A | - | - | - | $2.5K | - | - | - | - | - | - |
| Operating Income | - | ($628.8K) | ($563.3K) | ($415.4K) | - | ($259.2K) | ($20.1K) | ($69.0K) | - | ($70.7K) |
| Interest Expense | - | $21.0K | $42.2K | $41.4K | - | $12.2K | - | - | - | - |
| Income Tax | - | - | - | - | - | - | - | - | - | - |
| Net Income | - | ($649.8K) | ($605.6K) | ($718.8K) | - | ($271.3K) | ($20.1K) | ($127.6K) | - | ($108.1K) |
| EPS - Basic | - | ($0.02) | ($0.02) | ($0.02) | - | ($0.01) | $0.00 | ($0.00) | - | - |
| EPS - Diluted | - | ($0.02) | ($0.02) | ($0.02) | - | ($0.01) | $0.00 | ($0.00) | - | - |
Balance Sheet
| Line item | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $132.2K | $38.9K | $4.7K | $129.3K | $6.2K | $16.2K | $294 | $244 | $224 | $4.6K |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | $93.6K | $158.8K | $74.4K | $70.0K | $68.8K | $3.5K | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | $322.7K | $197.7K | $93.1K | $201.2K | $76.8K | $156.1K | $294 | $244 | $244 | $129.0K |
| Total Assets | $390.0K | $9.27M | $9.43M | $9.81M | $9.95M | $19.29M | $294 | $244 | $244 | $129.0K |
| Current Liabilities | $1.61M | $1.50M | $1.04M | $1.66M | $1.34M | $953.8K | $103.0K | $82.8K | $13.8K | $14.9K |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $1.61M | $1.50M | $1.04M | $1.67M | $1.35M | $977.4K | $103.0K | $82.8K | $13.8K | $14.9K |
| Stockholders' Equity | ($1.22M) | $7.77M | $8.40M | $8.14M | $8.60M | $18.31M | ($102.7K) | ($82.6K) | ($13.5K) | $114.1K |
| Retained Earnings | ($13.61M) | ($4.62M) | ($3.97M) | ($3.37M) | ($2.91M) | ($2.19M) | ($1.49M) | ($1.47M) | ($1.40M) | ($1.27M) |
Cash Flow
| Line item | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | ($164.8K) | - | - | - | ($73.0K) | - | - |
| Investing Cash Flow | - | - | - | ($41.5K) | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | $225.4K | - | - | - | $45.7K | - | - |
| CapEx | - | - | - | $41.5K | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | ($206.2K) | - | - | - | - | - | - |
Ratios
| Metric | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | 70.1% | 26.4% | 19.9% | - | 41.3% | - | - | - | 100.0% |
| Operating margin | - | -10203.0% | -3886.4% | -3052.2% | - | -1207.9% | - | - | - | -1561.1% |
| EBITDA margin | - | - | - | -3033.9% | - | - | - | - | - | - |
| Net margin | - | -10543.2% | -4177.7% | -5281.3% | - | -1264.5% | - | - | - | -2389.4% |
| Free cash flow margin | - | - | - | -1515.2% | - | - | - | - | - | - |
| FCF / Net income | - | - | - | 0.29 | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | 10044.3% | 3840.3% | 2930.5% | - | 1194.7% | - | - | - | 1561.1% |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | - | -7.0% | -6.4% | -7.3% | - | -1.4% | -6842.2% | -52292.6% | - | -83.9% |
| Return on equity | - | -8.4% | -7.2% | -8.8% | - | -1.5% | 19.6% | 154.5% | - | -94.8% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.20 | 0.13 | 0.09 | 0.12 | 0.06 | 0.16 | 0.00 | 0.00 | 0.02 | 8.65 |
| Quick ratio | 0.14 | 0.03 | 0.02 | 0.08 | 0.01 | 0.16 | 0.00 | 0.00 | 0.02 | 8.65 |
| Cash ratio | 0.08 | 0.03 | 0.00 | 0.08 | 0.00 | 0.02 | 0.00 | 0.00 | 0.02 | 0.31 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | -30.0x | -13.3x | -10.0x | - | -21.3x | - | - | - | - |
| Equity multiplier | -0.32 | 1.19 | 1.12 | 1.20 | 1.16 | 1.05 | -0.00 | -0.00 | -0.02 | 1.13 |
| Liabilities / Assets | 4.13 | 0.16 | 0.11 | 0.17 | 0.14 | 0.05 | 350.25 | 339.37 | 56.49 | 0.12 |
| Efficiency | ||||||||||
| Asset turnover | - | 0.00 | 0.00 | 0.00 | - | 0.00 | - | - | - | 0.04 |
| Inventory turnover | - | 0.01 | 0.02 | 0.16 | - | 0.28 | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | 31503d | 16578d | 2345d | - | 1282d | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | -71.3% | - | - | - | 374.1% | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | -51.2% | - | - | - | 95.8% | - | - | - | - |
| Operating income growth (YoY) | - | -142.6% | -2700.4% | -501.8% | - | -266.8% | 77.9% | - | - | - |
| Net income growth (YoY) | - | -139.5% | -2910.4% | -463.3% | - | -150.9% | 77.9% | - | - | - |
| EPS growth (YoY) | - | -100.0% | - | -3233.3% | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | - | -57.6% | - | - | - | 15951.8% | - | - | - | - |
Peer comparison
Same SIC group: Pharmaceutical Preparations
Comparing Trustfeed Corp. against the 5 most active filers in the same SIC group.